Engrafting Horse Immune Cells into Mouse Hosts for the Study of the Acute Equine Immune Responses.
NSG
equine
lymphocyte response
xenograft
Journal
Animals : an open access journal from MDPI
ISSN: 2076-2615
Titre abrégé: Animals (Basel)
Pays: Switzerland
ID NLM: 101635614
Informations de publication
Date de publication:
14 Oct 2021
14 Oct 2021
Historique:
received:
31
08
2021
revised:
05
10
2021
accepted:
11
10
2021
entrez:
23
10
2021
pubmed:
24
10
2021
medline:
24
10
2021
Statut:
epublish
Résumé
Immunological studies in the horse are frequently hampered by lack of environmental control, complicated study design, and ethical concerns when performing high risk studies. The purpose of the current study was to investigate the utility of a xenograft model for studying acute equine immune responses. Immunocompromised non obese diabetic (NOD). sudden combined immunodeficiency (scid).gamma-/- (NSG) mice were engrafted with either equine peripheral blood lymphocytes (PBLs) or equine bone marrow to determine an optimal protocol for equine lymphocyte engraftment. We found that both PBL and bone marrow grafts populated the host mice successfully. Bone marrow transplants were technically more challenging and required further processing to retard graft versus host disease. Graft vs host disease was apparent at 28 days post-PBL transfer and 56 days post-bone marrow transfer. The results of these studies support the use of mouse hosts to study acute equine immune responses and that different engraftment techniques can be used depending on the experimental design.
Identifiants
pubmed: 34679981
pii: ani11102962
doi: 10.3390/ani11102962
pmc: PMC8532756
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Institute of Food and Agriculture
ID : 1019507
Organisme : VMCVM Internal Research Competition
ID : 178626
Organisme : Virginia Horse Industry Board
ID : n/a
Références
J Immunol. 2020 Mar 1;204(5):1091-1100
pubmed: 31988182
Mol Ther. 2012 May;20(5):882-4
pubmed: 22549804
Animals (Basel). 2021 Aug 12;11(8):
pubmed: 34438836
PLoS One. 2011;6(6):e20169
pubmed: 21695116
J Immunol. 2017 Jun 1;198(11):4255-4267
pubmed: 28461573
Hematol Oncol Clin North Am. 1990 Jun;4(3):687-98
pubmed: 2193019
Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15589-94
pubmed: 20713716
Vet Immunol Immunopathol. 2014 Feb 15;157(3-4):131-41
pubmed: 24368085
Diabetes. 2016 Mar 9;65(7):1977-1987
pubmed: 26961115
PLoS One. 2018 Dec 12;13(12):e0209034
pubmed: 30540841
Vet Immunol Immunopathol. 1993 Dec;39(4):315-25
pubmed: 8116213
Nat Rev Immunol. 2012 Nov;12(11):786-98
pubmed: 23059428
J Am Assoc Lab Anim Sci. 2014 May;53(3):301-6
pubmed: 24827573
Vet Immunol Immunopathol. 1997 Oct 6;59(1-2):93-112
pubmed: 9437828
J Exp Med. 1978 Dec 1;148(6):1687-98
pubmed: 363972
Vet Immunol Immunopathol. 1993 Sep;38(1-2):21-44
pubmed: 8256436
Virulence. 2011 May-Jun;2(3):248-52
pubmed: 21623167
Curr Protoc Immunol. 2008 May;Chapter 15:Unit 15.21
pubmed: 18491294
Cells. 2019 May 06;8(5):
pubmed: 31064068
Methods. 2013 Feb;59(2):249-57
pubmed: 22687621
Cold Spring Harb Perspect Med. 2012 May;2(5):a007757
pubmed: 22553498
J Immunother Cancer. 2017 Dec 19;5(1):98
pubmed: 29254507
Res Vet Sci. 2014 Oct;97(2):386-90
pubmed: 25104320
J Am Assoc Lab Anim Sci. 2019 Mar 1;58(2):246-250
pubmed: 30764891
Blood. 2007 Jan 1;109(1):212-8
pubmed: 16954502